Title of article :
Potent quinoxaline-Based inhibitors of PDGF receptor tyrosine kinase activity. Part 2: the synthesis and biological activities of RPR127963 an orally bioavailable inhibitor
Author/Authors :
Wei He، نويسنده , , Michael R. Myers، نويسنده , , Barbara Hanney، نويسنده , , Alfred P. Spada، نويسنده , , Glenda Bilder، نويسنده , , Helen Galzcinski، نويسنده , , Dilip Amin، نويسنده , , Saul Needle، نويسنده , , Ken Page، نويسنده , , Zaid Jayyosi، نويسنده , , Mark H. Perrone، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2003
Pages :
4
From page :
3097
To page :
3100
Abstract :
RPR127963 demonstrates an excellent pharmacokinetic profile in several species and was found to be efficacious in the prevention of restenosis in a Yucatan mini-pig model upon oral administration of 1–5 mg/kg. The in vitro selectivity profile and SAR of the highly optimized PDGF-R tyrosine kinase inhibitor are highlighted.
Journal title :
Bioorganic & Medicinal Chemistry Letters
Serial Year :
2003
Journal title :
Bioorganic & Medicinal Chemistry Letters
Record number :
793517
Link To Document :
بازگشت